YTHDF3 Human Pre-designed siRNA Set A
Based on 2 publication(s) in Google Scholar
YTHDF3 Human Pre-designed siRNA Set A contains three designed siRNAs for YTHDF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
For research use only. We do not sell to patients.
-
Storage:
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications Citing Use of MedChemExpress (MCE) YTHDF3 Human Pre-designed siRNA Set A
More
Biological Activity
YTHDF3 Human Pre-designed siRNA Set A contains three designed siRNAs for YTHDF3 gene (Human), as well as a negative control, a positive control, and a FAM-labeled negative control.
Components
YTHDF3 siRNA-1: 5 nmol (HPLC)
YTHDF3 siRNA-2: 5 nmol (HPLC)
YTHDF3 siRNA-3: 5 nmol (HPLC)
siRNA Negative Control: 5 nmol (HPLC)
FAM-labeled siRNA Negative Control: 5 nmol (HPLC)
GAPDH siRNA Positive Control: 5 nmol (HPLC)
|
YTHDF3 |
YTHDF3 - YTH N6-methyladenosine RNA binding protein 3 Gene (Human)
DF3
Chemical Information
-
Shipping
Room temperature in continental US; may vary elsewhere.
-
Storage
Please store the product under the recommended conditions in the Certificate of Analysis.
Publications (2)
-
Journal Impact Factor
-
Most Recent
-
NPJ Precis Oncol
TRMT6-directed m1A modification initiates lung squamous cell carcinoma via YTHDF3-stabilized cell cycle genes. [Abstract]2026 Mar 10;10(1):165. PMID: 41803297 -
J Biochem Mol Toxicol
METTL3-Mediated m6A Methylation Stabilizes IFI27 to Drive Esophageal Squamous Cell Carcinoma Progression Through an IGF2BP2-Dependent Mechanism. [Abstract]2025 Mar;39(3):e70167. PMID: 39987518
Purity & Documentation
Calculators
Concentration (start) × Volume (start) = Concentration (final) × Volume (final)